Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microcystin-LR aerosol exposure increases inflammatory drivers of asthma, Evidence of an NF-κB amplification mechanism.

bioRxiv : the preprint server for biology·2025
Same author

Identification of a conserved RNA structure in the <i>TNFRSF1A</i> 3'UTR: Implications for post-transcriptional regulation.

bioRxiv : the preprint server for biology·2025
Same author

Acute Exposure to Aerosolized Nanoplastics Modulates Redox-Linked Immune Responses in Human Airway Epithelium.

Antioxidants (Basel, Switzerland)·2025
Same author

Aerosolized Harmful Algal Bloom Toxin Microcystin-LR Induces Type 1/Type 17 Inflammation of Murine Airways.

Toxins·2024
Same author

Safety, Tolerability, and Pharmacokinetics of an Oral Small Molecule Inhibitor of IL-17A (LY3509754): A Phase I Randomized Placebo-Controlled Study.

Clinical pharmacology and therapeutics·2024
Same author

Immunity to pathogenic mucosal C. albicans infections mediated by oral megakaryocytes activated by IL-17 and candidalysin.

Mucosal immunology·2024

Related Experiment Video

Updated: May 24, 2026

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens
08:47

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens

Published on: April 5, 2019

Human platelets efficiently kill IgG-opsonized E. coli.

Anum H Riaz1, Brian E Tasma, Michael E Woodman

  • 1Department of Medical Microbiology & Immunology, University of Toledo College of Medicine, Toledo, OH 43614, USA.

FEMS Immunology and Medical Microbiology
|February 21, 2012
PubMed
Summary
This summary is machine-generated.

Platelets can kill bacteria, especially when coated with IgG antibodies. This bacterial killing ability is FcγRIIA-dependent and may help protect against infections.

More Related Videos

Automated, High-Throughput Detection of Bacterial Adherence to Host Cells
07:21

Automated, High-Throughput Detection of Bacterial Adherence to Host Cells

Published on: September 17, 2021

Purification of Platelets from Mouse Blood
05:41

Purification of Platelets from Mouse Blood

Published on: May 7, 2019

Related Experiment Videos

Last Updated: May 24, 2026

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens
08:47

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens

Published on: April 5, 2019

Automated, High-Throughput Detection of Bacterial Adherence to Host Cells
07:21

Automated, High-Throughput Detection of Bacterial Adherence to Host Cells

Published on: September 17, 2021

Purification of Platelets from Mouse Blood
05:41

Purification of Platelets from Mouse Blood

Published on: May 7, 2019

Area of Science:

  • Immunology
  • Hematology
  • Microbiology

Background:

  • Platelets are crucial for hemostasis.
  • Emerging evidence highlights platelet roles in inflammation and infectious diseases.
  • Thrombocytopenia is common in sepsis patients.

Purpose of the Study:

  • To investigate the role of human platelets in host defense against bacterial infections.
  • To determine if platelets can kill Escherichia coli.
  • To elucidate the mechanisms underlying platelet-mediated bacterial killing.

Main Methods:

  • Human platelets were incubated with unopsonized or IgG-opsonized Escherichia coli.
  • Platelet binding and bacterial killing were evaluated.
  • The role of FcγRIIA, cytochalasin D, and reactive oxygen metabolites was assessed.

Main Results:

  • Platelets associated with both unopsonized and IgG-opsonized E. coli.
  • Efficient killing of E. coli occurred only with IgG-opsonized bacteria, unless platelets were activated.
  • Bactericidal activity was dependent on FcγRIIA and sensitive to cytochalasin D, but independent of reactive oxygen metabolites.

Conclusions:

  • Human platelets possess bactericidal capacity against E. coli.
  • This activity is primarily mediated through FcγRIIA engagement with IgG-opsonized bacteria.
  • Platelets may represent a significant component of the innate immune system against bacterial infections.